dopamine < dopaminergic < dopaminomimetic

Facettes :

List of bibliographic references indexed by dopaminergic

Number of relevant bibliographic references: 169.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000034 (2017)	Jeffrey H. Kordower [États-Unis] ; Christopher G. Goetz [États-Unis] ; Yaping Chu [États-Unis] ; Glenda M. Halliday [Australie] ; Daniel A. Nicholson [États-Unis] ; Timothy F. Musial [États-Unis] ; David J. Marmion [États-Unis] ; A Jon Stoessl [Canada] ; Vesna Sossi [Canada] ; Thomas B. Freeman [États-Unis] ; C Warren Olanow [États-Unis]	Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a Parkinson disease patient.
000094 (2017)	Nadhir Litim [Canada] ; Marc Morissette [Canada] ; Thérèse Di Paolo [Canada]	Effects of progesterone administered after MPTP on dopaminergic neurons of male mice.
000157 (2016)	James B. Koprich [Canada] ; Tom H. Johnston [Canada] ; Gabriela Reyes [Canada] ; Vanessa Omana [Canada] ; Jonathan M. Brotchie [Canada]	Towards a Non-Human Primate Model of Alpha-Synucleinopathy for Development of Therapeutics for Parkinson’s Disease: Optimization of AAV1/2 Delivery Parameters to Drive Sustained Expression of Alpha Synuclein and Dopaminergic Degeneration in Macaque
000180 (2016)	Daniel J. Cameron [Canada] ; Kristen A. Pickett [États-Unis] ; Gammon M. Earhart [États-Unis] ; Jessica A. Grahn [Canada]	The Effect of Dopaminergic Medication on Beat-Based Auditory Timing in Parkinson’s Disease
000191 (2016)	Jean-François Daneault [Canada] ; Benoit Carignan [Canada] ; Abbas F. Sadikot [Canada] ; Christian Duval [Canada]	Subthalamic deep brain stimulation and dopaminergic medication in Parkinson's disease: Impact on inter-limb coupling.
000251 (2016)	Katherine Coulombe [Canada] ; Martine Saint-Pierre [Canada] ; Giulia Cisbani [Canada] ; Isabelle St-Amour [Canada] ; Claire Gibrat [Canada] ; Ariane Giguère-Rancourt [Canada] ; Frédéric Calon [Canada] ; Francesca Cicchetti [Canada]	Partial neurorescue effects of DHA following a 6-OHDA lesion of the mouse dopaminergic system.
000264 (2016)	Imène Achour [Canada] ; Anne-Marie Arel-Dubeau [Canada] ; Justine Renaud [Canada] ; Manon Legrand [Canada] ; Everaldo Attard [Malte] ; Marc Germain [Canada] ; Maria-Grazia Martinoli [Canada]	Oleuropein Prevents Neuronal Death, Mitigates Mitochondrial Superoxide Production and Modulates Autophagy in a Dopaminergic Cellular Model.
000301 (2016)	Hélène Doucet-Beaupré [Canada] ; Catherine Gilbert [Canada] ; Marcos Schaan Profes [Canada] ; Audrey Chabrat [Canada] ; Consiglia Pacelli [Canada] ; Nicolas Giguère [Canada] ; Véronique Rioux [Canada] ; Julien Charest [Canada] ; Qiaolin Deng [Suède] ; Ariadna Laguna [Suède] ; Johan Ericson [Suède] ; Thomas Perlmann [Suède] ; Siew-Lan Ang [Royaume-Uni] ; Francesca Cicchetti [Canada] ; Martin Parent [Canada] ; Louis-Eric Trudeau [Canada] ; Martin Lévesque [Canada]	Lmx1a and Lmx1b regulate mitochondrial functions and survival of adult midbrain dopaminergic neurons.
000413 (2016)	John L. Goudreau [États-Unis] ; Adriana Pérez [États-Unis] ; Michael J. Aminoff [États-Unis] ; James T. Boyd [États-Unis] ; Keith D. Burau [États-Unis] ; Chadwick W. Christine [États-Unis] ; Maureen Leehey [États-Unis] ; John C. Morgan [États-Unis]	Choice of dopaminergic therapy among early, mild Parkinson disease subjects in North America.
000476 (2015)	Kaylena A. Ehgoetz Martens [Canada] ; Colin G. Ellard [Canada] ; Quincy J. Almeida [Canada]	Virtually-induced threat in Parkinson's: Dopaminergic interactions between anxiety and sensory-perceptual processing while walking.
000505 (2015)	Matt J N. Brown [Canada] ; Quincy J. Almeida ; Fariborz Rahimi	The dopaminergic system in upper limb motor blocks (ULMB) investigated during bimanual coordination in Parkinson's disease (PD).
000573 (2015)	M. Yue [États-Unis] ; K. Hinkle [États-Unis] ; P. Davies [Royaume-Uni] ; E. Trushina [États-Unis] ; F. Fiesel [États-Unis] ; T. Christenson [États-Unis] ; A. Schroeder [États-Unis] ; L. Zhang [États-Unis] ; E. Bowles [États-Unis] ; B. Behrouz [États-Unis] ; S. Lincoln [États-Unis] ; J. Beevers [États-Unis] ; A. Milnerwood [Canada] ; A. Kurti [États-Unis] ; P. J. Mclean [États-Unis] ; J. D. Fryer [États-Unis] ; W. Springer [États-Unis] ; D. Dickson [États-Unis] ; M. Farrer [Canada] ; H. Melrose [États-Unis]	Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock in mice
000619 (2015)	Hooman Ganjavi [Canada] ; Penny A. Macdonald	ON-OFF Effects of Dopaminergic Therapy on Psychiatric Symptoms in Parkinson's Disease.
000643 (2015)	Angela Anderegg [États-Unis] ; Jean-Francois Poulin [États-Unis] ; Rajeshwar Awatramani [États-Unis]	Molecular heterogeneity of midbrain dopaminergic neurons--Moving toward single cell resolution.
000648 (2015)	Yueting Shao [Canada] ; Daniel Figeys ; Zhibin Ning ; Ryan Mailloux ; Hing Man Chan	Methylmercury can induce Parkinson's-like neurotoxicity similar to 1-methyl-4- phenylpyridinium: a genomic and proteomic analysis on MN9D dopaminergic neuron cells.
000800 (2015)	Rafael Godoy [Canada] ; Sandra Noble [Canada] ; Kevin Yoon [Canada] ; Hymie Anisman [Canada] ; Marc Ekker [Canada]	Chemogenetic ablation of dopaminergic neurons leads to transient locomotor impairments in zebrafish larvae.
000849 (2015)	Daryl J. Wile [Canada] ; Katie Dinelle [Canada] ; Nasim Vafai [Canada] ; Jessamyn Mckenzie [Canada] ; Joseph K. Tsui [Canada] ; Paul Schaffer [Canada] ; Yu-Shin Ding [États-Unis] ; Matthew Farrer [Canada] ; Vesna Sossi [Canada] ; A. Jon Stoessl [Canada]	A Scan Without Evidence Is Not Evidence of Absence: Scans Without Evidence of Dopaminergic Deficit in a Symptomatic Leucine-Rich repeat Kinase 2 Mutation Carrier
000904 (2014)	Magda Osman [Royaume-Uni] ; Agata Ryterska [Royaume-Uni] ; Kash Karimi [Royaume-Uni] ; Lingling Tu [République populaire de Chine] ; Ignacio Obeso [Canada] ; Maarten Speekenbrink [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni]	The effects of dopaminergic medication on dynamic decision making in Parkinson's disease.
000959 (2014)	Jackalina M. Van Kampen [Canada] ; David Baranowski [Canada] ; Denis G. Kay [Canada]	Progranulin Gene Delivery Protects Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease
000991 (2014)	Chizoba C. Umeh [États-Unis] ; Adriana Pérez [États-Unis] ; Erika F. Augustine [États-Unis] ; Rohit Dhall [États-Unis] ; Richard B. Dewey [États-Unis] ; Zoltan Mari [États-Unis] ; David K. Simon [États-Unis] ; Anne-Marie A. Wills [États-Unis] ; Chadwick W. Christine [États-Unis] ; Jay S. Schneider [États-Unis] ; Oksana Suchowersky [Canada]	No Sex Differences in Use of Dopaminergic Medication in Early Parkinson Disease in the US and Canada - Baseline Findings of a Multicenter Trial
000A10 (2014)	Penelope J. Hallett [États-Unis] ; Oliver Cooper [États-Unis] ; Damaso Sadi [Canada] ; Harold Robertson [Canada] ; Ivar Mendez [Canada] ; Ole Isacson [États-Unis]	Long-term dopamine transporter expression and normal cellular distribution of mitochondria in dopaminergic neuron transplants in Parkinson’s disease patients

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "dopaminergic" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "dopaminergic" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    dopaminergic
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022